Michael Schmertzler, Director at PTC Therapeutics, holds 123.27K shares in PTC Therapeutics (Ticker: PTCT), holds 725.00K shares in Hamilton Lane (Ticker: HLNE), holds 4.34M shares in Cytokinetics (Ticker: CYTK).

See the Hottest Stocks Based on Insider Trading >

Michael Schmertzler
PTC Therapeutics (PTCT)
Director

Ranked #10,216 out of 98,624 Corporate Insiders

Profitable Transactions

4 out of 4 Profitable Transactions

Average Return

+48.10%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

76.22%

CYTK

22.61%

HLNE

1.17%

PTCT

A breakdown of Michael Schmertzler's holdings

See the Top Stocks by Insiders

Insider Roles

Cytokinetics
(CYTK)

See Exhibit 1

Hamilton Lane
(HLNE)

Ten Percent Owner

PTC Therapeutics
(PTCT)

Director

Roles that Michael Schmertzler holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

PTC Therapeutics
(PTCT)

Rating:Informative Buy

Date:Jan 29, 2019 - Jan 29, 2020

Return:+81.70%

The most profitable trade made by Michael Schmertzler

See the Latest Stocks Traded by Insiders

Michael Schmertzler's Trading History

PTCT

PTC Therapeutics

Feb 16, 2024

Director

Uninformative Buy

―

$4.21M

HLNE

Hamilton Lane

Mar 08, 2021

Ten Percent Owner

Uninformative Sell

―

$81.59M

CYTK

Cytokinetics

Jun 07, 2010

See Exhibit 1

Informative Sell

16.15K

$275.08M

List of latest transactions for each holding click on a transaction to see Michael Schmertzler's performance on stock

See All Insider Trading from Today

Michael Schmertzler insider profile FAQ

What is the percentage of profitable transactions made by Michael Schmertzler?

The percentage of profitable transactions made by Michael Schmertzler is 100%.

What is the average return per transaction made by Michael Schmertzler?

The average return per transaction made by Michael Schmertzler is 48.10%.

What stocks does Michael Schmertzler hold?

Michael Schmertzler holds: PTCT, HLNE, CYTK stocks.

What was Michael Schmertzler’s latest transaction?

Michael Schmertzler latest transaction was an Uninformative Buy of ―.

What was Michael Schmertzler's most profitable transaction?

Michael Schmertzler’s most profitable transaction was an Informative Buy of PTCT stock on January 29, 2019. The return on the trade was 81.70%.

What is Michael Schmertzler's role in PTC Therapeutics?

Michael Schmertzler's role in PTC Therapeutics is Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Michael Schmertzler Insider Profile

Michael Schmertzler PTC Therapeutics (PTCT)Director